| |
| |
|
| Insider
Information: |
Hannah Alison L. |
| Relationship: |
Chief Medical Officer |
| City: |
Fort Myers |
| State: |
FL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
180,025 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,367,766 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
180,025 |
|
|
| Total
Value |
$1,367,766 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
NeoGenomics Inc |
NEO |
Director |
2021-06-02 |
91,877 |
|
0 |
Premium* |
|
|
Rigel Pharmaceuticals Inc |
RIGL |
|
2023-05-26 |
56,250 |
2021-05-19 |
0 |
Premium* |
|
|
Cytomx Therapeutics, Inc. |
CTMX |
Chief Medical Officer |
2022-07-20 |
31,898 |
2022-02-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
18 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RIGL |
Rigel Pharmaceuticals Inc |
|
• • – |
2023-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
56,250 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2022-07-20 |
4 |
S |
$1.42 |
$7,965 |
D/D |
(5,602) |
31,898 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2022-07-19 |
4 |
A |
$0.00 |
$0 |
D/D |
15,000 |
37,500 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
|
• • – |
2022-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
25,000 |
31,250 |
0 |
- |
|
| CTMX |
Cytomx Therapeutics, Inc. |
Chief Medical Officer |
• – – |
2022-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
22,500 |
22,500 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
3,081 |
91,877 |
0 |
- |
|
| RIGL |
Rigel Pharmaceuticals Inc |
Director |
– • – |
2021-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
6,250 |
6,250 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
Director |
– • – |
2020-08-06 |
4 |
OE |
$7.27 |
$72,700 |
D/D |
10,000 |
88,796 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
Director |
– • – |
2020-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,698 |
78,796 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
Director |
– • – |
2019-09-09 |
4 |
OE |
$6.66 |
$98,111 |
D/D |
11,666 |
76,098 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
Director |
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
3,419 |
64,432 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
Director |
– • – |
2018-06-01 |
4 |
A |
$0.00 |
$0 |
D/D |
15,564 |
61,013 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
Director |
– • – |
2017-08-09 |
4 |
OE |
$6.66 |
$44,402 |
D/D |
6,667 |
45,449 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
Director |
– • – |
2017-07-27 |
4 |
B |
$9.19 |
$183,800 |
D/D |
20,000 |
38,782 |
2.39 |
- |
|
| NEO |
NeoGenomics Inc |
Director |
– • – |
2017-05-30 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,222 |
18,782 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
Director |
– • – |
2016-04-20 |
4 |
A |
$7.15 |
$15,373 |
D/D |
2,150 |
13,710 |
0 |
- |
|
| NEO |
NeoGenomics Inc |
Director |
– • – |
2016-03-03 |
4 |
B |
$6.90 |
$69,000 |
D/D |
10,000 |
11,560 |
2.39 |
- |
|
| NEO |
NeoGenomics Inc |
Director |
– • – |
2015-06-12 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,560 |
|
- |
|
18 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
